Patient characteristics
| Characteristic . | Data . |
|---|---|
| Age, y | 44 (19-83) |
| Sex, n (%) | |
| Males | 23 (53) |
| Females | 20 (47) |
| PNH clone size, % | |
| Granulocytes | 87.9 (18.2-99.8) |
| Monocytes | 88.9 (16.6-99.8) |
| Erythrocytes type II | 4.3 (0.1-87.3) |
| Erythrocytes type III | 38.9 (1.0-88.8) |
| Prophylactic antibiotic use, n (%) | 1 (2) |
| Median time between prevaccination and postfirst vaccination blood draw, d | 84 (56-112) |
| Median time between postfirst and postsecond vaccination blood draw, d | 84 (70-181) |
| Characteristic . | Data . |
|---|---|
| Age, y | 44 (19-83) |
| Sex, n (%) | |
| Males | 23 (53) |
| Females | 20 (47) |
| PNH clone size, % | |
| Granulocytes | 87.9 (18.2-99.8) |
| Monocytes | 88.9 (16.6-99.8) |
| Erythrocytes type II | 4.3 (0.1-87.3) |
| Erythrocytes type III | 38.9 (1.0-88.8) |
| Prophylactic antibiotic use, n (%) | 1 (2) |
| Median time between prevaccination and postfirst vaccination blood draw, d | 84 (56-112) |
| Median time between postfirst and postsecond vaccination blood draw, d | 84 (70-181) |
Unless otherwise noted, data are median (range).